Drug intelligence / Profile preview

compound amino acid capsules

Development stage: Unknown
Lead developer: Lepu Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Compound amino acid capsules are a nutritional pharmaceutical product developed by Lepu Pharmaceutical, marketed under the brand name Shuaiqing (帅清). The formulation contains a balanced mixture of essential and non-essential amino acids designed to address protein-energy malnutrition and hypoalbuminemia. It is indicated for patients with chronic liver disease, cirrhosis, renal dysfunction, and those recovering from major surgery or suffering from malignant tumors. The supplement works by providing the necessary precursors for protein synthesis, thereby helping to maintain nitrogen balance and support the recovery of plasma albumin levels in catabolic or protein-deficient states.

Brand names: 帅清Shuaiqing
Other names: Compound Amino Acid Capsules

Beyond the preview

Go deeper on compound amino acid capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on compound amino acid capsules.

Explore the full profile